January 10, 2017
Futura Medical nets licensing deal with STADA for its pain relief gel
Futura Medical (Futura) has signed a licensing agreement with the UK subsidiary of STADA Arzneimittel AG (STADA), for the commercialisation of TPR100, its pain relief gel.